Evidence-based guides for UK clinicians — medical journal digests, CPD reading strategies, and staying current with the literature.
Journal digest or medical podcast — which is the better way for UK doctors to keep current? A practical comparison of retention, CPD value, and time efficiency.
The best medical journal digest apps for iOS and Android in 2026 — compared on offline reading, CPD logging, and what actually works on an NHS commute.
A simple CPD reflection template for UK doctors logging journal reading — with worked examples and guidance for appraisal-ready entries.
How to turn the reading you already do into documented CPD your appraiser will accept — with exact examples and a template.
The 2026 NICE NG28 update made SGLT2 inhibitors first-line for most adults with type 2 diabetes. A practical guide to UK primary-care prescribing — agents, eligibility, cautions, sick-day rules, and what still requires metformin.
Heidi Evidence is the most-anticipated UK-relevant clinical AI tool of 2026 — and NHS email addresses are blocked from signing up. This is the third UK AI exclusion in six weeks. Here's what to do.
The 18 February 2026 NICE NG28 update is the biggest change to UK type 2 diabetes prescribing in years. SGLT2 inhibitors are now first-line for almost all adults. Here's a plain-English summary for busy UK clinicians.
ChatGPT for Clinicians launched in April 2026 but explicitly excludes the UK and EEA. Here's what it does, why UK doctors are locked out, and what's actually available.
Five peer-reviewed palliative care papers, every Monday. Plain-language summaries, written for NHS clinicians by a serving consultant in the specialty.
A transparent breakdown of journal summary subscription pricing in the UK — what you pay, what you get, and how to judge value against time saved.
NEJM Journal Watch is now NEJM Clinician. Here's how it compares to The Monday Clinical Brief in 2026 — price, coverage, UK alignment, and which one fits your workflow.
UpToDate and MCB solve different problems. One is a reference you consult. The other is a digest that keeps you current. Most UK doctors need both — here's why.
OpenEvidence is gone from the UK. Here's what actually fills the gap — and why staying current with the literature is a different problem from clinical Q&A.
Free journal alerts or a paid summary subscription? A practical comparison of coverage, signal-to-noise, and time cost for busy UK doctors.
A 2026 comparison of BMJ summaries, NEJM Clinician, UpToDate Expert AI, Heidi Evidence, OpenEvidence, ChatGPT for Clinicians, and independent digests like MCB — pricing, coverage, UK availability, and value for UK clinicians.
Heidi Evidence is free and powerful — but it solves a different problem. Here's why UK doctors still need a weekly digest alongside evidence lookup tools.
A practical comparison of CPD reading tools for UK doctors — what they track, how they integrate with appraisal portfolios, and which suits your workflow.
A head-to-head comparison of journal digest services available to UK doctors — features, pricing, CPD integration, and specialty coverage.
Everything UK doctors need to know about CPD reading — what counts, how to log it, and how to make every reading minute count for revalidation.
Feeling overwhelmed by the volume of medical journals? You are not alone. Here is what evidence-based doctors actually do to stay current.
The most notable papers published this week across major medical journals — quick clinical summaries for doctors who don't have time to read everything.
Five practical strategies for busy UK doctors to stay current with the medical literature — without sacrificing every evening and weekend.
How to turn your journal reading into verifiable CPD credits — with tools, templates, and strategies for UK doctors preparing for appraisal and revalidation.
Compare journal summary subscription services for UK doctors. What to look for, how they work, and why The Monday Clinical Brief covers 31 specialties for £20/year.
The definitive guide to medical journal digests — what they are, how they work, and why thousands of UK clinicians rely on them to stay evidence-based.